Hydrodynamic properties of 2-mercaptoethanol-modified glycogen

Glycan vesicle formation in vitellocytes and hatching vacuoles in eggs of Echinostoma caproni and Fasciola hepatica (Digenea)

Vitelline cells, which are added to the fertilized ovum when eggs are formed in Platyhelminthes, are known to produce and secrete proteins containing vesicles for construction of the eggshell. In this study, another particular type of carbohydrate-containing vesicle is described, in the vitellocytes of Digenea. These vesicles play a role in the hatching of the miracidium from the egg. Cytochemical analysis and the binding of lectins with specificities for a variety of sugar residues revealed that the vesicles contain neutral, glycogen-like polysaccharides composed of glucosyl/mannosyl residues. The vesicles are produced at a late maturation stage of the vitellarium cells. Vitellocytes enclosed in the eggs provide nutrients for the embryo, but retain the glycan vesicles until late embryogensis. Then the vesicles merge and swell to the dimensions of the vitellocytes, and these coalesce into two vacuoles that fill the space between the embryo and the eggshell. Hatching of the miracidium is induced by exposure to light and a slight rise in temperature, i.e. conditions found in the natural environment in the morning. The eggs' internal hydrostatic pressure rises, probably due to a depolymerization of the polysaccharides that causes an osmotically driven water influx. Finally, the operculum of the egg bursts open and the miracidium escapes.

Molecular and metabolic aspects of lysosomal glycogen

The high molecular weight glycogen associated with the lysosomal compartment in glycogen storage disease type VIII is more resistant to degradation by proteinase than normal glycogen. The assembly of large glycogen particles on disulphide-linked protein backbones has been confirmed and the disulphide-reducing nature of the lysosome appears to confer an advantage in the amylolytic degradation of glycogen. Experiments utilising acarbose, a lysosomal (1----4)-alpha-D-glucosidase inhibitor, show that some blood glucose could arise in normal mammals from extra-hepatic tissue, by degradation of the glycogen in the lysosomal compartment.

Heterogeneity of glycogen synthesis upon refeeding following starvation

1. Starvation of rats for 40 hr decreased the body weight, liver weight and blood glucose concentration. The hepatic and skeletal muscle glycogen concentrations were decreased by 95% (from 410 mumol/g tissue to 16 mumol/g tissue) and 55% (from 40 mumol/g tissue to 18.5 mumol/g tissue), respectively. 2. Fine structural analysis of glycogen purified from the liver and skeletal muscle of starved rats suggested that the glycogenolysis included a lysosomal component, in addition to the conventional phosphorolytic pathway. In support of this the hepatic acid alpha-glucosidase activity increased 1.8-fold following starvation. 3. Refeeding resulted in liver glycogen synthesis at a linear rate of 40 mumol/g tissue per hr over the first 13 hr of refeeding. The hepatic glycogen store were replenished by 8 hr of refeeding, but synthesis continued and the hepatic glycogen content peaked at 24 hr (approximately 670 mumol/g tissue). 4. Refeeding resulted in skeletal muscle glycogen synthesis at an initial rate of 40 mumol/g tissue per hr. The muscle glycogen store was replenished by 30 min of refeeding, but synthesis continued and the glycogen content peaked at 13 hr (approximately 50 mumol/g tissue). 5. Both liver and skeletal muscle glycogen synthesis were inhomogeneous with respect to molecular size; high molecular weight glycogen was initially synthesised at a faster rate than low molecular weight glycogen. These observations support suggestions that there is more than a single site of glycogen synthesis.

The discovery of glycogenin and the priming mechanism for glycogen biogenesis

The biogenesis of glycogen in skeletal muscle requires a priming mechanism that has recently been elucidated. The first step is catalysed by a protein tyrosine glucosyltransferase and involves the formation of a novel glycosidic linkage, namely the covalent attachment of glucose to a single tyrosine residue (Tyr194) on a priming protein, termed glycogenin. The next stage is the extension of the glucan chain from Tyr194 and involves the sequential addition of up to seven further glucosyl residues. This reaction is brought about autocatalytically by glycogenin itself, which is a Mn2+/Mg(2+)-dependent UDP-Glc-requiring glucosyltransferase. The glucan primer is elongated by glycogen synthase, but only when glycogenin and glycogen synthase are complexed together. Glycogen synthase dissociates from glycogenin during the synthesis of a glycogen molecule, enabling glycogen molecules to reach their maximum theoretical size. Each mature glycogen beta particle in muscle contains one molecule of glycogenin attached covalently, and an average one glycogen synthase catalytic subunit bound non-covalently. As evidence accumulates that a priming protein may be a fundamental property of polysaccharide synthesis in general, the molecular details of mammalian glycogen biogenesis may serve as a useful model for other systems.

Post mortem glycogenolysis is a combination of phosphorolysis and hydrolysis

1. Glycogen, glucose, lactate and glycogen phosphorylase concentrations and the activities of glycogen phosphorylase a and acid 1,4-alpha-glucosidase were measured at various times up to 120 min after death in the liver and skeletal muscle of Wistar and gsd/gsd (phosphorylase b kinase deficient) rats and Wistar rats treated with the acid alpha-glucosidase inhibitor acarbose. 2. In all tissues glycogen was degraded rapidly and was accompanied by an increase in tissue glucose and lactate concentrations and a lowering of tissue pH. In the liver of Wistar and acarbose-treated Wistar rats and in the skeletal muscle of all rats glycogen loss proceeded initially very rapidly before slowing. In the gsd/gsd rat liver glycogenolysis proceeded at a linear rate throughout the incubation period. Over 120 min 60, 20 and 50% of the hepatic glycogen store was degraded in the livers of Wistar, gsd/gsd and acarbose-treated Wistar rats, respectively. All 3 types of rat degraded skeletal muscle glycogen at the same rate and to the same extent (82% degraded over 2 hr). 3. In Wistar rat liver and skeletal muscle glycogen phosphorylase was activated soon after death and the activity of phosphorylase a remained well above the zero-time level at all later time points, even when the rate of glycogenolysis had slowed significantly. Liver and skeletal muscle acid alpha-glucosidase activities were unchanged after death. 4. The decreased rate and extent of hepatic glycogenolysis in both the gsd/gsd and acarbose-treated rats suggests that this process is a combination of phosphorolysis and hydrolysis. 5. Glycogen was purified from Wistar liver and skeletal muscle at various times post mortem and its structure investigated. Fine structural analysis revealed progressive shortening of the outer chains of the glycogen from both tissues, indicative of random, lysosomal hydrolysis. Analysis of molecular weight distributions showed inhomogeneity in the glycogen loss; in both tissues high molecular weight glycogen was preferentially degraded. This material is concentrated in lysosomes of both skeletal muscle and liver. These results are consistent with a role for lysosomal hydrolysis in glycogen degradation.

Acarbose is a competitive inhibitor of mammalian lysosomal acid alpha-D-glucosidases

Intraperitoneal injections (approximately 400 mg/kg of body weight) of acarbose, an inhibitor of acid (1----4)-alpha-D-glucosidase, perturb the metabolism of glycogen in the liver, resulting in excess storage of lysosomal glycogen. The metabolism of skeletal muscle glycogen was unaffected, suggesting that acarbose either does not enter the tissue or that the muscle alpha-D-glucosidase is not inhibited. The hydrolysis of maltose and glycogen by the acid alpha-D-glucosidases from rat liver, rat skeletal muscle, and human placenta was inhibited competitively by acarbose. Thus, the lack of effect of acarbose upon the metabolism of muscle glycogen is due to its inability to enter the tissue.

Structural and functional studies on rabbit liver glycogenin

Glycogenin, the protein primer required for the biogenesis of muscle glycogen, has been isolated from rabbit liver glycogen. The protein comprised 0.0025% of liver glycogen by mass, 200-fold lower than the glycogenin content of muscle glycogen. Structural analyses, including determination of the amino acid sequence surrounding the glucosylated-tyrosine residue, showed identity with muscle glycogenin. Catalytically active liver glycogenin was partially purified and, like the skeletal muscle protein, catalysed an intramolecular, Mn2+- and UDP-Glc-dependent autoglucosylation reaction, forming a primer on which glycogen synthase could act. The results demonstrate that hepatic and muscle glycogenins are almost certainly identical proteins and that liver and skeletal muscle share a common mechanism for the biogenesis of glycogen molecules. The results also indicate that there is about one glycogenin molecule/liver glycogen alpha particle.

Regulation of lysosomal glycogen metabolism: studies of the actions of mammalian acid alpha-glucosidases

1. Acid alpha-glucosidases were purified to homogeneity from rat liver, rat skeletal muscle and human placenta. The properties of these enzymes were investigated. 2. Their pH optima for activity toward various substrates were in the range 4-5. 3. Time course and pH dependence experiments revealed that all glycogen substrates were not hydrolysed at the same rate; the rate of hydrolysis was inversely related to the molecular size of the substrate. The most rapidly hydrolysed glycogen substrate was the smallest (commercial oyster) while the least rapidly hydrolysed was the largest (native rat or rabbit liver). Intermediate sized glycogens were hydrolysed at intermediate rates. 4. Glycogen hydrolysis was stimulated by added sodium ions; this stimulation was pH dependent. 5. It is suggested that lysosomal glycogen metabolism may be controlled by pH, salt concentration and the size of the glycogen substrate. 6. Since the high molecular weight glycogen associated with lysosomes is formed by disulphide bridges between lower molecular weight material it is proposed that an important step of lysosomal glycogen degradation is disulphide bond reduction.

Rat skeletal muscle lysosomes contain glycogen

1. A lysosome- and mitochondria-enriched fraction was obtained from rat skeletal muscle using a differential centrifugation procedure. This fraction contained a proportion (3-4%) of the tissue glycogen content. 2. Lysosomes and mitochondria were separated from one another by centrifugation of a cell-free extract upon discontinuous Ficoll-sucrose gradients. Little glycogen was associated with the resulting mitochondrial fraction. The lysosomal fraction, however, contained a significant amount of glycogen, accounting for 5% of the skeletal muscle glycogen. 3. The lysosomal glycogen was purified and found to be enriched in high molecular weight material. 4. The compartmentation of skeletal muscle glycogen metabolism is suggested.

The structure of placental glycogen

Glycogen was purified from human term placenta and its structural features investigated. The beta-amylolysis limit and average chain lengths indicated that some degradation of the glycogen had occurred prior to its extraction. The sedimentation coefficient distribution of the purified glycogen showed that it contained a significant proportion of aggregated material. Diffusion coefficient measurements allowed calculation of the molecular weight distribution. The placental glycogen contained a significant proportion of high molecular weight material, although not as much as liver or skeletal muscle glycogens. Because the high molecular weight glycogen of liver and skeletal muscle is associated with the lysosome it is likely that this is also true of the large placental glycogen. Lysosomal glycogen is degraded hydrolytically to glucose and so placental glycogen may be involved in fetal glucose homeostasis.

A (1----4)-alpha-D-glucan-protein involved in liver glycogen biosynthesis

A macromolecular (1----4)-alpha-D-[14C]glucan-protein complex was synthesized with a rat liver preparation and uridine diphosphate D-[14C]glucose. The size of the complex is contributed by both the protein and the (1----4)-alpha-D-glucosyl-oligomer components. Iodoacetamide treatment did not change the migration properties on Bio-Gel A-50m. Therefore, disulfide bonds linking glucan-protein subunits seem not to be involved. The [14C]glucan-protein, precipitated by diluted trichloroacetic acid, was digested by alpha-amylase, phosphorylase a, and proteases. The extent of proteolysis was greater for a complex having fewer D-glucose units incorporated. After proteolytic digestion of that complex, the labeled fragments behaved on electrophoresis, and ion-exchange and gel chromatography as [14C]glucosylated peptides. These findings support previous conclusions that the primer for liver glycogen synthesis is a protein on which glycogen is built up by covalent attachment.

Compartmentation of glycogen metabolism in the liver

The incorporation of radioactivity into liver glycogen has been shown not only to be a metabolically inhomogeneous process but also to depend critically on the nature of the precursor. D-Galactose is incorporated into glycogen by a mechanism which is separate from that associated with the incorporation of D-glucose. D-Galactose is favoured for incorporation into high-molecular-weight glycogen and consequently is affected more by treatment of the animal with the antibiotic tunicamycin, since high-molecular-weight glycogen is preferentially found in the lysosomal compartment.

Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor

The 1,4-alpha-glucosidase inhibitor. Acarbose, when injected intraperitoneally disturbs liver lysosome metabolism, causing distinct and persistent inhibition of the enzymes and acute disturbances of lysosomal glycogen metabolism. A feedback control mechanism appears to operate, affecting cytosolic carbohydrate metabolism. A model is suggested for the adult form of lysosomal storage disease. The biochemical effects closely resemble those occurring in glycogenosis type II (Pompe's disease), and these have been confirmed by electron microscopy.

Factors affecting the metabolic control of cytosolic and lysosomal glycogen levels in the liver

Rats with a gentic deficiency of phosphorylase kinase have been treated with the 1,4-alpha-glucosidase inhibitor, Acarbose. Lysosomal glycogen metabolism has been markedly altered and the results support the concept of a feedback control mechanism operating on the uptake mechanism into the lysosomal compartment.

Glycogen of high molecular weight from mammalian muscle

Glycogen of high molecular weight has been isolated from mammalian muscle, in contrast to the material of low molecular weight commonly described. The large polysaccharide is similar to liver glycogen in the structure of its individual beta-particles and also, partially, in the mode of assembly into the gross alpha-particles. The large particles may be disrupted by 2-mercaptoethanol, but not to the same extent as their liver counterparts.

Ordered synthesis and degradation of liver glycogen involving 2-amino-2-deoxy-D-glucose

The incorporation of 2-amino-2-deoxy-D-glucose from precursor 2-amino-2-deoxy-D-galactose into liver glycogen has been shown to be a metabolically inhomogeneous process after starvation. The protein-to-polysaccharide ratio is also heterogeneous with respect to molecular size, and enhanced overall as compared to normal glycogen. The results are discussed from the viewpoint of a molecular order in the synthesis and degradation of liver glycogen.

Disturbance of lysosomal glycogen metabolism by liposomal anti-alpha-glucosidase and some anti-inflammatory drugs

The size-distribution of liver glycogen was shown to be distinctly affected by the anti-inflammatory drugs salicylate and indomethacin. By measurement of the incorporation of radioactive glucose into glycogen, salicylate was shown to have a depressing effect on overall liver glycogen metabolism. These effects appear to arise from the stabilizing of the lysosome by the drugs. The incorporation, via liposomes, of purified anti-1,4-alpha-glucosidase activity and in the content of high-molecular-weight glycogen. These changes are increased by prolonged liposomal antibody treatment and suggest that a possible feedback control mechanism operates in the incorporation of glycogen into lysosomes. These experiments may be useful as a model of glycogen turnover and its failure in glycogenosis type II (Pompe's disease).